{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:28:40Z","timestamp":1787099320843,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI096299"],"award-info":[{"award-number":["U01AI096299"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13790-w","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:34:55Z","timestamp":1781235295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Variability in HIV viral load quantification in real-world service delivery settings: findings from an observational cohort study in Rwanda"],"prefix":"10.1186","volume":"26","author":[{"given":"Gad","family":"Murenzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Brazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Gertrude","family":"Rutwaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Paul","family":"Mivumbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Barthel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyne","family":"Ingabire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faustin","family":"Kanyabwisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Yotebieng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"13790_CR1","volume-title":"Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV","author":"World Health Organization (WHO)","year":"2015","unstructured":"World Health Organization (WHO). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization; 2015."},{"issue":"25","key":"13790_CR2","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJMp2113118","volume":"385","author":"J Bor","year":"2021","unstructured":"Bor J, Onoya D, Richman B, Mayer KH. A Failure to Disseminate Transformative Science - HIV Treatment as Prevention, 10 Years On. N Engl J Med. 2021;385(25):2305\u20137.","journal-title":"N Engl J Med"},{"key":"13790_CR3","unstructured":"Prevention Access Campaign. Prevention Access Campaign. Available from: https:\/\/preventionaccess.com\/."},{"key":"13790_CR4","unstructured":"World Health Organization (WHO). The role of HIV viral suppression in improving individual health and reducing transmission: policy brief Geneva: World Health Organization. 2023. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/360860\/9789240055179-eng.pdf?sequence=1."},{"issue":"Suppl 1","key":"13790_CR5","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.jcv.2011.09.015","volume":"52","author":"BR Cobb","year":"2011","unstructured":"Cobb BR, Vaks JE, Do T, Vilchez RA. Evolution in the sensitivity of quantitative HIV-1 viral load tests. J Clin Virol. 2011;52(Suppl 1):S77\u201382.","journal-title":"J Clin Virol"},{"issue":"8","key":"13790_CR6","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/QAD.0000000000001779","volume":"32","author":"K White","year":"2018","unstructured":"White K, Garner W, Wei L, Eron JJ, Zhong L, Miller MD, et al. Repeat testing of low-level HIV-1 RNA: assay performance and implementation in clinical trials. Aids. 2018;32(8):1053\u20137.","journal-title":"Aids"},{"issue":"4","key":"13790_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/154510970200100405","volume":"1","author":"DN Chernoff","year":"2002","unstructured":"Chernoff DN. The significance of HIV viral load assay precision: a review of the package insert specifications of two commercial kits. J Int Assoc Physicians AIDS Care (Chic). 2002;1(4):134\u201340.","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"issue":"2","key":"13790_CR8","doi-asserted-by":"publisher","first-page":"e0171155","DOI":"10.1371\/journal.pone.0171155","volume":"12","author":"VD Lima","year":"2017","unstructured":"Lima VD, Wang L, Brumme C, Wu L, Montaner JSG, Harrigan PR. Estimation of measurement error in plasma HIV-1 RNA assays near their limit of quantification. PLoS ONE. 2017;12(2):e0171155.","journal-title":"PLoS ONE"},{"key":"13790_CR9","doi-asserted-by":"publisher","first-page":"104530","DOI":"10.1016\/j.jcv.2020.104530","volume":"129","author":"P Braun","year":"2020","unstructured":"Braun P, Glass A, Maree L, Kr\u00fcgel M, Pacenti M, Onelia F, et al. Multicenter clinical comparative evaluation of Alinity m HIV-1 assay performance. J Clin Virol. 2020;129:104530.","journal-title":"J Clin Virol"},{"key":"13790_CR10","doi-asserted-by":"publisher","first-page":"104644","DOI":"10.1016\/j.jcv.2020.104644","volume":"132","author":"L Maree","year":"2020","unstructured":"Maree L, Kr\u00fcgel M, Reinhardt B, Glass AJ. Evaluation of the Alinity m HIV-1 assay for the quantification of HIV-1 RNA plasma viral load in a high-throughput molecular laboratory in South Africa. J Clin Virol. 2020;132:104644.","journal-title":"J Clin Virol"},{"issue":"12","key":"13790_CR11","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1002\/jmv.25877","volume":"92","author":"N Lelie","year":"2020","unstructured":"Lelie N, van Drimmelen H. Accuracy of quantitative HIV-1 RNA test methods at 1000 copies\/mL and the potential impact of differences in assay calibration on therapy monitoring of patients. J Med Virol. 2020;92(12):3246\u201353.","journal-title":"J Med Virol"},{"issue":"10","key":"13790_CR12","doi-asserted-by":"publisher","first-page":"e26359","DOI":"10.1002\/jia2.26359","volume":"27","author":"AM Parcesepe","year":"2024","unstructured":"Parcesepe AM, Stockton M, Bernard C, Kanguya T, Kwobah EK, Lopez A, et al. Prevalence and co-occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low- and middle-income countries: a cross-sectional study. J Int AIDS Soc. 2024;27(10):e26359.","journal-title":"J Int AIDS Soc"},{"key":"13790_CR13","unstructured":"International epidemiology Databases to Evaluate AIDS (IeDEA). Sentinel Research Network (SRN) 2025. Available from: https:\/\/www.iedea.org\/working-groups\/sentinel-research-network-srn\/?cn-reloaded=1."},{"key":"13790_CR14","unstructured":"Association of Public Health Laboratories (APHL). Use and interpretation of quantitative HIV-1 RNA test results testing and reporting guidance for laboratories 2025. Available from: https:\/\/www.aphl.org\/aboutAPHL\/publications\/Documents\/ID_HIV-1_RNA_Test_Reporting_Guide.pdf."},{"issue":"3","key":"13790_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276\u201382.","journal-title":"Biochem Med (Zagreb)"},{"issue":"7","key":"13790_CR16","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702\u20136.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"13790_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.11613\/BM.2015.015","volume":"25","author":"D Giavarina","year":"2015","unstructured":"Giavarina D. Understanding Bland Altman analysis. Biochem Med (Zagreb). 2015;25(2):141\u201351.","journal-title":"Biochem Med (Zagreb)"},{"issue":"1","key":"13790_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1128\/JCM.01285-10","volume":"49","author":"EJ van Rensburg","year":"2011","unstructured":"van Rensburg EJ, Tait K, Watt A, Schall R. Comparative evaluation of the Roche Cobas AmpliPrep\/Cobas TaqMan HIV-1 version 2 test using the TaqMan 48 analyzer and the Abbott RealTime HIV-1 assay. J Clin Microbiol. 2011;49(1):377\u20139.","journal-title":"J Clin Microbiol"},{"key":"13790_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jcv.2017.09.007","volume":"96","author":"M Wirden","year":"2017","unstructured":"Wirden M, Larrouy L, Mahjoub N, Todesco E, Damond F, Delagreverie H, et al. Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep\/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load. J Clin Virol. 2017;96:49\u201353.","journal-title":"J Clin Virol"},{"key":"13790_CR20","doi-asserted-by":"publisher","first-page":"104331","DOI":"10.1016\/j.jcv.2020.104331","volume":"126","author":"L Mouna","year":"2020","unstructured":"Mouna L, Pallier C, Proust S, Pr\u00e9germain C, Roque-Afonso AM. Comparison of the Abbott Alinity m and m2000 assays for the quantification of HIV-1, HCV and HBV in clinical samples. J Clin Virol. 2020;126:104331.","journal-title":"J Clin Virol"},{"issue":"1","key":"13790_CR21","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.4102\/AJLM.v13i1.2364","volume":"13","author":"DR Hardie","year":"2024","unstructured":"Hardie DR, Newman H, Reid J, Hsiao NY, van Zyl G, Hans L, et al. Field study to determine the reliability of HIV viral load results shows minimal impact of delayed testing in South Africa. Afr J Lab Med. 2024;13(1):2364.","journal-title":"Afr J Lab Med"},{"issue":"8","key":"13790_CR22","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1128\/JCM.00578-12","volume":"50","author":"C Jennings","year":"2012","unstructured":"Jennings C, Harty B, Granger S, Wager C, Crump JA, Fiscus SA, et al. Cross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation. J Clin Microbiol. 2012;50(8):2737\u201347.","journal-title":"J Clin Microbiol"},{"key":"13790_CR23","unstructured":"Ministry of Health (Rwanda). National Guidelines for Prevention and Management of HIV. 2021."},{"issue":"7","key":"13790_CR24","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/cid\/civ1034","volume":"62","author":"W Garner","year":"2016","unstructured":"Garner W, White K, Szwarcberg J, McCallister S, Zhong L, Wulfsohn M. Concordance of HIV-1 RNA Values by Amplicor and TaqMan 2.0 in Patients With Confirmed Suppression in Clinical Trials. Clin Infect Dis. 2016;62(7):929\u201334.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"13790_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/QAI.0b013e31819e721b","volume":"51","author":"V Lima","year":"2009","unstructured":"Lima V, Harrigan R, Montaner JS. Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay. J Acquir Immune Defic Syndr. 2009;51(1):3\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"13790_CR26","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1086\/592693","volume":"47","author":"PF Rebeiro","year":"2008","unstructured":"Rebeiro PF, Kheshti A, Bebawy SS, Stinnette SE, Erdem H, Tang YW, et al. Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures. Clin Infect Dis. 2008;47(10):1354\u20137.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"13790_CR27","doi-asserted-by":"publisher","first-page":"e0219381","DOI":"10.1371\/journal.pone.0219381","volume":"14","author":"D Hardie","year":"2019","unstructured":"Hardie D, Korsman S, Ameer S, Vojnov L, Hsiao N-Y. Reliability of plasma HIV viral load testing beyond 24 hours: Insights gained from a study in a routine diagnostic laboratory. PLoS ONE. 2019;14(7):e0219381.","journal-title":"PLoS ONE"},{"issue":"3","key":"13790_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/QAI.0b013e3181aa13b3","volume":"51","author":"E Smit","year":"2009","unstructured":"Smit E, Bhattacharya S, Osman H, Taylor S. Increased Frequency of HIV-1 Viral Load Blip Rate Observed After Switching From Roche Cobas Amplicor to Cobas Taqman Assay. JAIDS J Acquir Immune Defic Syndr. 2009;51(3):364\u20135.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"12","key":"13790_CR29","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1093\/cid\/ciz936","volume":"70","author":"TA Crowell","year":"2019","unstructured":"Crowell TA, Pinyakorn S, Sacdalan C, Kroon E, Colby DJ, Puttamaswin S, et al. Viral Blips After Treatment Initiation During Acute Human Immunodeficiency Virus Infection. Clin Infect Dis. 2019;70(12):2706\u20139.","journal-title":"Clin Infect Dis"},{"key":"13790_CR30","doi-asserted-by":"crossref","unstructured":"Han WM, Broom J, Bopage R, Templeton DJ, Edmiston N, Petoumenos K. Investigating rates and predictors of viral blips, low-level viraemia and virological failure in the Australian HIV observational database. Tropical medicine & international health: TM & IH. 2024;29(1):42\u201356.","DOI":"10.1111\/tmi.13951"},{"issue":"10","key":"13790_CR31","doi-asserted-by":"publisher","first-page":"e29178","DOI":"10.1002\/jmv.29178","volume":"95","author":"PGA Oomen","year":"2023","unstructured":"Oomen PGA, Dijkstra S, Hofstra LM, Nijhuis MM, Verbon A, Mudrikova T, et al. Integrated analysis of viral blips, residual viremia, and associated factors in people with HIV: Results from a retrospective cohort study. J Med Virol. 2023;95(10):e29178.","journal-title":"J Med Virol"},{"issue":"1","key":"13790_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/cid\/ciac762","volume":"76","author":"O Elvstam","year":"2023","unstructured":"Elvstam O, Malmborn K, El\u00e9n S, Marrone G, Garc\u00eda F, Zazzi M, et al. Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort. Clin Infect Dis. 2023;76(1):25\u201331.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"13790_CR33","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1093\/cid\/ciz129","volume":"69","author":"C Joya","year":"2019","unstructured":"Joya C, Won SH, Schofield C, Lalani T, Maves RC, Kronmann K, et al. Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure. Clin Infect Dis. 2019;69(12):2145\u201352.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13790-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13790-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13790-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:18:44Z","timestamp":1787098724000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13790-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13790"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13790-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the Declaration of Helsinki, and the IeDEA SRN study protocol was approved by the Rwanda National Ethics Committee (224\/RNEC\/2020), the University Integrated Institutional Review Board (IRB) of the City University of New York (#2018-0809-PHHP) and the Albert Einstein College of Medicine (#2020\u201311247). All participants provided written informed consent to voluntarily participate in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1526"}}